MDGL
Price
$298.87
Change
-$1.28 (-0.43%)
Updated
Jul 3 closing price
Capitalization
6.64B
33 days until earnings call
ONC
Price
$245.49
Change
+$1.17 (+0.48%)
Updated
Jul 3 closing price
Capitalization
28.31B
49 days until earnings call
Interact to see
Advertisement

MDGL vs ONC

Header iconMDGL vs ONC Comparison
Open Charts MDGL vs ONCBanner chart's image
Madrigal Pharmaceuticals
Price$298.87
Change-$1.28 (-0.43%)
Volume$108.67K
Capitalization6.64B
BeOne Medicines
Price$245.49
Change+$1.17 (+0.48%)
Volume$172.49K
Capitalization28.31B
MDGL vs ONC Comparison Chart in %
Loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDGL vs. ONC commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a StrongBuy and ONC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (MDGL: $298.87 vs. ONC: $245.49)
Brand notoriety: MDGL and ONC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 33% vs. ONC: 50%
Market capitalization -- MDGL: $6.64B vs. ONC: $28.31B
MDGL [@Biotechnology] is valued at $6.64B. ONC’s [@Biotechnology] market capitalization is $28.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 0 FA rating(s) are green whileONC’s FA Score has 0 green FA rating(s).

  • MDGL’s FA Score: 0 green, 5 red.
  • ONC’s FA Score: 0 green, 5 red.
According to our system of comparison, MDGL is a better buy in the long-term than ONC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 5 TA indicator(s) are bullish while ONC’s TA Score has 5 bullish TA indicator(s).

  • MDGL’s TA Score: 5 bullish, 4 bearish.
  • ONC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than ONC.

Price Growth

MDGL (@Biotechnology) experienced а -0.21% price change this week, while ONC (@Biotechnology) price change was -3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

MDGL is expected to report earnings on Aug 06, 2025.

ONC is expected to report earnings on Aug 22, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONC($28.3B) has a higher market cap than MDGL($6.64B). ONC YTD gains are higher at: 32.906 vs. MDGL (-3.144). ONC has higher annual earnings (EBITDA): -116.48M vs. MDGL (-376.15M). ONC has more cash in the bank: 2.52B vs. MDGL (843M). MDGL has less debt than ONC: MDGL (120M) vs ONC (997M). ONC has higher revenues than MDGL: ONC (4.18B) vs MDGL (317M).
MDGLONCMDGL / ONC
Capitalization6.64B28.3B23%
EBITDA-376.15M-116.48M323%
Gain YTD-3.14432.906-10%
P/E RatioN/AN/A-
Revenue317M4.18B8%
Total Cash843M2.52B34%
Total Debt120M997M12%
FUNDAMENTALS RATINGS
MDGL vs ONC: Fundamental Ratings
MDGL
ONC
OUTLOOK RATING
1..100
1262
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
4276
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
5546
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ONC's Valuation (58) in the Biotechnology industry is in the same range as MDGL (64) in the Pharmaceuticals Other industry. This means that ONC’s stock grew similarly to MDGL’s over the last 12 months.

MDGL's Profit vs Risk Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for ONC (76) in the Biotechnology industry. This means that MDGL’s stock grew somewhat faster than ONC’s over the last 12 months.

ONC's SMR Rating (93) in the Biotechnology industry is in the same range as MDGL (97) in the Pharmaceuticals Other industry. This means that ONC’s stock grew similarly to MDGL’s over the last 12 months.

ONC's Price Growth Rating (46) in the Biotechnology industry is in the same range as MDGL (55) in the Pharmaceuticals Other industry. This means that ONC’s stock grew similarly to MDGL’s over the last 12 months.

ONC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MDGL (100) in the Pharmaceuticals Other industry. This means that ONC’s stock grew similarly to MDGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDGLONC
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 7 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
69%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QSPT29.660.14
+0.46%
FT Vest Nasdaq-100® Buffer ETF Sep
GJT22.60N/A
N/A
Synthetic Fixed-Income Securities STRATS 2006-3 AllState Corp
JULJ24.81-0.01
-0.02%
Innovator Premium Income 30 Bar ETF -Jul
JBND53.17-0.14
-0.26%
JPMorgan Active Bond ETF
ERH11.52-0.04
-0.32%
Allspring Utilities and High Income Fund

ONC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
+0.48%
ZLAB - ONC
55%
Loosely correlated
+2.56%
MDGL - ONC
42%
Loosely correlated
-0.43%
WXXWY - ONC
37%
Loosely correlated
+0.08%
AXON - ONC
37%
Loosely correlated
+2.70%
GOSS - ONC
35%
Loosely correlated
+2.48%
More